Self-renewing cell populations such as hematopoietic stem cells and memory B and T lymphocytes might be regulated by shared signaling pathways 1 . The Wnt-b-catenin pathway is an evolutionarily conserved pathway that promotes hematopoietic stem cell self-renewal and multipotency by limiting stem cell proliferation and differentiation 2,3 , but its role in the generation and maintenance of memory T cells is unknown. We found that induction of Wnt-b-catenin signaling by inhibitors of glycogen sythase kinase-3b or the Wnt protein family member Wnt3a arrested CD8 + T cell development into effector cells. By blocking T cell differentiation, Wnt signaling promoted the generation of CD44 low CD62L high Sca-1 high CD122 high Bcl-2 high self-renewing multipotent CD8 + memory stem cells with proliferative and antitumor capacities exceeding those of central and effector memory T cell subsets. These findings reveal a key role for Wnt signaling in the maintenance of 'stemness' in mature memory CD8 + T cells and have major implications for the design of new vaccination strategies and adoptive immunotherapies.
Self-renewing cell populations such as hematopoietic stem cells and memory B and T lymphocytes might be regulated by shared signaling pathways 1 . The Wnt-b-catenin pathway is an evolutionarily conserved pathway that promotes hematopoietic stem cell self-renewal and multipotency by limiting stem cell proliferation and differentiation 2, 3 , but its role in the generation and maintenance of memory T cells is unknown. We found that induction of Wnt-b-catenin signaling by inhibitors of glycogen sythase kinase-3b or the Wnt protein family member Wnt3a arrested CD8 + T cell development into effector cells. By blocking T cell differentiation, Wnt signaling promoted the generation of CD44 low CD62L high Sca-1 high CD122 high Bcl-2 high self-renewing multipotent CD8 + memory stem cells with proliferative and antitumor capacities exceeding those of central and effector memory T cell subsets. These findings reveal a key role for Wnt signaling in the maintenance of 'stemness' in mature memory CD8 + T cells and have major implications for the design of new vaccination strategies and adoptive immunotherapies.
T cell factor-1 (Tcf-1) and lymphoid enhancer-binding factor-1 (Lef-1) are downstream transcription factors of the Wnt-b-catenin signaling pathway. Tcf-1 and Lef-1 are required for normal thymic T cell development, but less is known about Wnt function in mature T cells 2, 4 . Although experiments using a multimerized Tcf-Lef binding site reporter system have revealed that Wnt signaling is active in mature CD8 + T cells, the impact of this pathway on this cell population has yet to be fully elucidated 5 . At least three lines of evidence indicate that Wnt signaling might regulate the maturation of post-Thymic T lymphocytes. CD8 + T cells from Tcf7 -/mice, which are missing the gene that encodes Tcf-1, show a more differentiated phenotype (CD44 high and CD62L low ) than wild-type (WT) T cells 6 7 and mice ( Supplementary Fig. 1 ). Finally, high levels of Ctnnb1 (which encodes b-catenin), Lef1 and Tcf7 have been detected in T cells with increased potential to form memory cells in vivo 8,9 . Thus, triggering the activities of the Wnt signaling transcription factors Tcf-1 and Lef-1 might promote stem-like self-renewal capacity in mature T cells.
. In addition, expression of Lef1 and Tcf7 decreases with progressive differentiation of CD8 + T cells from naive T cells (T N cells) to central memory T cells (T CM cells) and effector memory T cells (T EM cells) in humans
To test the impact of Wnt-b-catenin signaling on mature CD8 + T cells, we primed T N cells in the presence of the 4,6-disubstituted pyrrolopyrimidine TWS119, a potent inhibitor of the serine-threonine kinase glycogen synthase kinase-3b (Gsk-3b) 10 . Gsk-3b blockade mimics Wnt signaling by promoting the accumulation of b-catenin, the molecule that tethers the Tcf and Lef transcription factors to targeted DNA 2 . TWS119 triggered a rapid accumulation of b-catenin (mean 6.8 ± s.d. 1.7-fold increase by densitometry; P o 0.05) ( Fig. 1a) , augmented nuclear protein interaction with oligonucleotide containing the DNA sequences to which Tcf and Lef bind ( Fig. 1b) and sharply upregulated the expression of Tcf7 (ref. 11), Lef1 (ref. 12) and other Wnt target genes including Jun 13 , Fzd7 (encoding Frizzled-7) 14 , Nlk (encoding Nemo-like kinase) 15 (Fig. 1c ). By contrast, T cell activation in the absence of the Gsk-3b inhibitor resulted in the downregulation of the Wnt-b-catenin signaling cascade ( Fig. 1a-c) . Thus, TWS119 activated the Wnt-b-catenin pathway in naive T cells and reversed the physiological downregulation of Tcf7 and Lef1 induced by T cell activation 7 .
We sought to assess the effect of Wnt signaling on CD8 + T cell differentiation and proliferation. We stimulated carboxyfluorescein succinimidyl ester (CFSE)-labeled CD8 + T cells from the gp100specific T cell receptor (TCR)-transgenic mouse, pmel-1 (ref. 16) , with its cognate antigen in the presence of titrated doses of TWS119 and analyzed them for the expression of the differentiation markers CD44 and CD62 ligand (CD62L). CD44 expression is known to increase with T cell differentiation, whereas CD62L expression is progressively lost 17 . Treatment of TWS119 increased the frequency of T cells that retained CD62L expression in a dose-dependent manner, indicating that it inhibits CD8 + T cell differentiation ( Fig. 2a) . Notably, 46% of CD8 + T cells cultured in the presence of the highest concentration of Gsk-3b inhibitor failed to upregulate CD44, maintaining a naive CD44 low CD62L high phenotype (Fig. 2a ). Low doses of TWS119 (r1 mM) preserved CD62L expression without affecting T cell proliferation, whereas higher TWS119 concentrations inhibited cell cycling in a dose-dependent manner (Fig. 2b) . Arrested differentiation and proliferation of CD8 + T cells mediated by TWS119 were not secondary to its impact on dendritic cells (DCs) because we observed similar results when we stimulated purified CD8 + T cells in a DC-free system ( Supplementary Fig. 2a,b ). Similarly to TWS119, the structurally unrelated Gsk-3b inhibitor 6-bromo-substituted indirubin, BIO 18, 19 , inhibited T cell differentiation ( Supplementary Fig. 3a ) and induced Tcf7 and Lef1 expression ( Supplementary Fig. 3b ). An analog with a greater Gsk-3b kinase inhibitory specificity, BIOacetoxime 19 retained the observed activity, whereas the N-methylated analog (methyl-BIO) 19 , which does not block the kinase activity of Gsk-3b, had no effect ( Supplementary Fig. 3a,b ). These results are in contrast with those obtained by other researchers using lithium chloride 20 , a less active and less specific Gsk-3b inhibitor 19 . Because Gsk-3b regulates several signaling pathways other than the Wnt pathway, we sought to more directly test whether the impact of the pharmacological blockade of Gsk-3b was dependent on mimicking the downstream signals of the Wnt-b-catenin pathway. We primed CD8 + T cells in the presence of Wnt3A, a Wnt protein that has been shown to promote hematopoietic stem cell self-renewal and pluripotency via b-catenin accumulation in the cell nucleus 21 . Similarly to TWS119, Wnt3A itself inhibited T cell differentiation and proliferation ( Supplementary Fig. 4) . Thus, T cell proliferation and differentiation could be restrained through the activation of the Wnt-b-catenin pathway by the naturally occurring ligand Wnt3A and by the pharamcologic inhibition of Gsk-3b downstream. Nevertheless, these data do not rule out the possibility that Gsk-3b inhibitors regulate T cell differentiation by affecting other pathways in addition to the Wnt pathway.
We sought to evaluate whether the phenotypic arrest of differentiation of pmel-1 CD8 + T cells that was induced by TWS119 was associated with a block in the acquisition of effector functions. It has been previously shown that differentiating CD8 + T cells lose the capacity to produce interleukin-2 (IL-2) as they acquire the ability to kill target cells and release large amounts of interferon-g (IFN-g) 17, 22 . We found that TWS119 induced a dose-dependent decrease in T cellspecific killing and IFN-g release associated with a preservation of the ability to produce IL-2 ( Fig. 2c) . These functional data confirmed our phenotypic findings that TWS119 was a negative regulator of effector T cell (T eff cell) differentiation. We next assessed whether inhibition of T eff cell development is associated with the suppression of eomesodermin (encoded by Eomes), a master regulator of CD8 + T cell effector function 23 . We found that exposure of cells to TWS119 abrogated the induced expression of Eomes that occurred within 8 h after T cell priming, indicating that TWS119mediated suppression of the effector program is an early event ( Fig. 2d) . Altogether, phenotypic, functional and molecular data indicated that induction of Wnt signaling during T cell priming results in inhibition of CD8 + T cell differentiation into T eff cells. Given our in vitro findings, we tested whether TWS119 can influence the qualities of adoptively transferred pmel-1 CD8 + T cells in response to fowlpox-based gp100 immunization and prevent the induction of highly differentiated, senescent T cells, a major pitfall of current T cellbased vaccines 24 . We found that there were no differences in frequency or numbers of pmel-1 T cells in spleens 6 d after vaccination, but development of T eff cells was inhibited ( Fig. 2e ). More notably, TWS119 effectively altered CD8 + T cell differentiation after immunization, as evidenced by increased numbers of CD44 high CD62L high T CM cells in responding CD8 + T cells after vaccination ( Fig. 2e ). However, we cannot ascertain whether the arrest of CD8 + T cell differentiation that we observed in vivo was a direct effect of TWS119 on this cell population or instead indirectly mediated through another cell type.
We observed a cell population that expressed low levels of CD44 and high levels of CD62L on the cell surface when we administered TWS119 in vitro and in vivo ( Fig. 2a,e ) but it was unclear whether these cells remained naive after antigen encounter or had entered into a primordial memory state that retained some phenotypic traits of T N cells. In a mouse model of graft-versus-host disease, other researchers have described a population of CD44 low CD62L high memory CD8 + T cells that express high cell surface levels of stem cell antigen-1 (Sca-1), B-cell lymphoma protein-2 (Bcl-2) and common IL-2 and IL-15 receptor b chain (CD122) 25 . Because these cells showed robust self-renewal and the multipotent capacity to generate T CM , T EM and T eff cells, they were designated 'T memory stem cells' (T SCM cells) 25 . We sought to explore whether the CD44 low CD62L high pmel-1 T cells that we generated in vitro with TWS119 treatment are T SCM cells. We found that the CD44 low CD62L high T cells generated after priming with antigen in the presence of TWS119 had undergone up to four divisions, as indicated by CFSE dilution, and uniformly expressed high cell surface levels of the core phenotypic markers of T SCM cells, namely Sca-1, CD122 and Bcl-2 ( Fig. 3a) . By contrast, freshly isolated T N cells expressed these markers in small amounts ( Fig. 3a) . Similarly, Sca-1, CD122 and Bcl-2 were upregulated in CD44 low CD62L high pmel-1 T cells generated in vitro in the presence of BIO-acetoxime ( Supplementary Fig. 5 ) or Wnt3A ( Supplementary Fig. 6 ) and in vivo after vaccination with gp100 and TWS119 administration ( Supplementary Fig. 7) . These activation and memory T cell markers were not exclusively expressed by T SCM cells but rather defined T SCM cells in the context of cells the were also CD44 low and CD62L high (data not shown). Antigen-experienced memory T cells can be distinguished from T N cells not only by phenotype but also by a number of functional properties, including rapid acquisition of effector functions upon antigen rechallenge [26] [27] [28] , pronounced cell cycling capacity 29 , robust homeostatic proliferation 30 and independence from major histocompatibility complex (MHC) class I for persistence 31 and antitumor activity 32 . We found that, unlike T N cells, TWS119-induced CD44 low CD62L high T cells rapidly released cytokines (IFN-g and IL-2) upon antigen encounter (Fig. 3b) , had undergone more cell division after adoptive transfer into a lymphoreplete host ( Fig. 3c ) or into sublethally irradiated or genetically lymphodepleted Tcra -/-(T celldeficient) or Rag1 -/-(T and B cell-deficient) hosts (Fig. 3d) , and persisted and mediated tumor destruction (P o 0.05) in B2m -/mice (which are MHC class I deficient) (Fig. 3e,f) . Altogether, these findings indicated that Wnt signaling induces the generation of a T SCM cell-like population that possesses the rapid recall ability, proliferative capacity and MHC class I independence that are characteristic of memory but not naive T cells. The concept of stemness encompasses the capability both to selfrenew and to generate more differentiated, specialized cells. We sought to determine the stemness of TWS119-generated CD44 low CD62L high T cells by evaluating the fate of these cells after adoptive transfer into sublethally irradiated mice. Four weeks later, we found that high percentages of TWS119-generated cells preserved their original CD44 low CD62L high phenotype even after multiple cell divisions, whereas T N cells rapidly acquired CD44 with progressive CFSE dilution (P o 0.02; Fig. 3g,h) . The differentiation of TWS119-induced 35  62  30  67   1   28  70  26  71  8  82  3  48  4  18   75  46  6  1 CD44 low CD62L high T cells was not arrested, however, because they acquired high CD44 expression, albeit at a slower pace than T N cells (Fig. 3g,h) . Unlike T N cells, TWS119-derived CD44 low CD62L high Sca-1 high T cells robustly proliferated (by 28 d after transfer into sublethally irradiated mice, 95% had undergone cell division) ( Fig. 3h) , enabling their reisolation and transfer to a secondary sublethally irradiated recipient ( Supplementary Fig. 8 ). After 4 weeks, we found that the secondarily transferred CD44 low CD62L high Sca-1 high T cells had again regenerated all T cell subsets. Notably, 43%
of the cells retained the T SCM phenotype in spite of a second round of robust proliferation in vivo ( Supplementary Fig. 8 ). These findings indicated that Wnt signaling promoted the generation of self-renewing, multipotent T SCM cells.
Having established that the CD44 low CD62L high T cells generated in the presence of TWS119 are bona fide T SCM cells and not merely naive, we sought to compare them with the well-defined memory T cell subsets, T CM cells and T EM cells, in secondary challenge experiments. We adoptively transferred highly purified pmel-1 memory On the next day, 1 Â 10 6 CD44 low CD62L high TWS119-treated or freshly isolated naive pmel-1 T cells were transferred in conjunction with intraperitoneal injection of IL-2. (g,h) Flow cytometry analysis of CFSE-labeled, sorted CD44 low CD62L high TWS119-treated or freshly isolated naive pmel-1 T cells congenically marked with Ly5.1 + 1 month after transfer into sublethally irradiated WT mice. Data are represented as the percentage of CD44 low CD62L high cells as a function of CFSE dilution of two independent experiments (g) or as fraction of cells with any given number of divisions (h). All data are representative of at least two independently performed experiments.
T cell subsets into sublethally irradiated mice in combination with recombinant vaccinia-based gp100 vaccine and IL-2 treatment. As previously reported by our group and others 33, 34 , the T CM cells proliferated more than T EM cells (Fig. 4a) . T SCM cells, however, robustly expanded by approximately 200-fold in the spleen alone (Fig. 4a) . These levels of expansion were approximately ten times higher than those of T CM cells and approximately 30 times higher than those of T EM cells (Fig. 4a) . Furthermore, T SCM cells showed an enhanced survival capacity, as revealed by the frequencies of pmel-1 T cells in the spleens of vaccinated mice 1 month after transfer (Fig. 4b) . T cell proliferative and survival capacities have been correlated with tumor responses in mice and humans receiving adoptive T cell-based therapies 35, 36 . To assess whether the enhanced replicative capability of T SCM cells would result in superior antitumor activity, we adoptively transferred limiting numbers of pmel-1 memory T cell subsets into sublethally irradiated hosts bearing B16 tumors, in combination with gp100 vaccine and IL-2. As we previously reported 33 , T CM cells conferred superior antitumor immunity compared with T EM cells (for tumor regression, P o 0.01; for overall survival, P ¼ 0.0644) (Fig. 4c) . Notably, minuscule numbers (4 Â 10 4 ) of T SCM cells were able to trigger the destruction of bulky tumors (1 cm 3 containing B1 Â 10 9 cells) and improve survival (T SCM cells versus T CM cells, P o 0.005; T SCM cells versus T EM cells, P o 0.005; Fig. 4c ). Thus, adoptive transfer of T SCM cells in combination with tumor antigen vaccination and exogenous IL-2 produced a far more robust and therapeutically noteworthy secondary response compared with the other memory T cell subsets.
Arrest of lymphocyte differentiation to maintain long-lived, selfrenewing antigen-experienced T cells with stem cell-like properties has been postulated as the basis of the continual generation of effector T cells 37 , but the transcription factors that regulate this process have not been fully elucidated. Although the physiologic role of Wnt signaling in post-Thymic T cell development remains unknown, our data indicate that Wnt can regulate the stemness of CD8 + T cells by suppressing their differentiation into T eff cells. Other circumstantial evidence supports our findings. We recently reported that high levels of the Wnt transcription factors Tcf7 and Lef1 were expressed by T cells whose antigen-induced development into T eff cells had been arrested using IL-21 in the culture medium 8 . Conversely, Tcf7 -/mice reportedly have an increased frequency of CD44 high CD62L low T EM cells 6 . Paralleling our own observations in CD8 + T cells, in CD4 + T cells expression of a stabilized form of b-catenin in CD4 + T cells inhibited the proliferation and effector function of the cells in a model of inflammatory bowel disease 38 . Furthermore, CD4 + T cell memory precursors overexpressed Ctnnb1 and Tcf7 as well as Bcl2 and Il2rb (ref. 9). These factors were all implicated in the formation and maintenance of T SCM cells described here.
Our findings also have parallels in stem cell biology, where Wnt signaling has a pivotal role in promoting self-renewal while limiting proliferation and differentiation 2, 3 . Hematopoietic stem cells exposed to an environment in which Wnt signaling was inhibited by overexpression of Dickkopf1 in the stem cell niche were more proliferative than those in WT mice, but they had lost their capacity for self renewal, as reflected by their inability to reconstitute hosts after serial transplants 3 . T cell lineage commitment to effector versus memory subsets has recently been linked to the asymmetrical segregation and inheritance of proteins that control cell fate specification 39 . Although the role of Wnt in the asymmetric division of CD8 + T cells is unknown, unequal localization and activities of Wnt signaling components, including b-catenin, have been implicated in cell fate specification in Caenorhabditis elegans 40 .
The ability to pharmacologically induce T SCM cells has considerable implications for the field of adoptive immunotherapy. The findings that small numbers of T SCM cells in conjunction with specific vaccination and IL-2 therapy can cause the regression of large established vascularized tumors might reduce the cost and complexity of highly effective therapies based on the adoptive transfer of antitumor T cells 35 . Using existing technology 36 , it may be possible to genetically engineer the human counterpart of CD8 + T SCM cells to express T cell receptors or chimeric antigen receptors while pharamacologically mimicking Wnt signaling. This might ultimately allow for the widespread application of adoptive immunotherapy based on multipotent, highly proliferative, tumor-specific T SCM cells. Finally, the modulation of Wnt signaling to induce long-term T cell memory might be crucial for T cell-based vaccines designed to target intracellular pathogens. Data indicate that protection against intracellular pathogens correlates with the induction and maintenance of T CM cell Figure 4 T SCM cells possess enhanced in vivo recall response and antitumor activity compared to T CM cells and T EM cells. Pmel-1 naive CD8 + T cells congenically marked with Thy1.1 were primed in vitro with splenocytes pulsed with 1 mM hgp100 [25] [26] [27] [28] [29] [30] [31] [32] [33] , in conjunction with 10 ng ml -1 IL-2 with or without 7 mM TWS119. Five days after antigenic stimulation, T SCM , T CM or T EM cells were sorted on the basis of phenotype (T SCM , CD44 low CD62L high cells; T CM , CD44 high CD62L high cells; T EM , CD44 high CD62L low cells). Sublethally irradiated WT mice received 5 Â responses, but these responses have not been reproducibly obtained with current vaccination strategies 24, 28, 34 . In vivo administration of small molecule agonists of Wnt signaling might be useful to consistently achieve this goal.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
